NHS: Drugs

Whilst there are no plans to undertake an independent review, the resilience of United Kingdom supply chains is a key priority, and the Department and NHS England are committed to helping to build long term supply chain resilience for medicines. We are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages.

The Department, working closely with NHS England, is taking forward a range of actions to further improve our ability to mitigate and manage shortages and strengthen our resilience. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency, and other colleagues across the supply chain as we progress work to co-design and deliver solutions. However, medicine shortages are a complex and global issue and everyone in the supply chain has a role to play in addressing them, and any action will require a collaborative approach.

In early August 2025, the Department published a policy paper, Managing a robust and resilient supply of medicines, which provides greater transparency of the supply chains we rely on, the actions we take to protect patients from medicines shortages when they occur, and the steps we are taking to enhance resilience in our supply chains. Later this year we will update on progress against commitments and will set out further actions to strengthen the resilience of our medicines supply chains. The paper is available at the following link:

https://www.gov.uk/government/publications/managing-a-robust-and-resilient-supply-of-medicines/managing-a-robust-and-resilient-supply-of-medicines